AMII

As the AMII chair comes up for election next month, Stephanie Spicer talks to outgoing chairman Mike Izzard on his tenure and the tasks ahead

The current subject on brokers' lips is PMI claims transparency, yet this was banned from discussion at a recent AMII meeting. In the absence of proper debate, Insurance Age's Liz McMahon brings viewpoints together

Senior industry figures have questioned Conservative plans to transfer regulatory powers from the FSA to either the Bank of England (BoE) or a new consumer protection body.

As the National Health Service comes under increasing financial strain, and the economic costs of sickness become more apparent, Michael Payne, outlines the part private medical insurance (PMI) could play through a restructure of current taxation rules...

Lead generation company Leadbay has launched a trial in private medical insurance leads with Best Health UK and Chase Templeton.

In light of the FSA's proposed regulatory fee increases for IFAs, do you think that advisers should have more input with the regulator on rules affecting their business? Should they be represented on the board?